B-Cell Non-Hodgkin’s Lymphoma characterisation by immunohistochemistry in Indigenous black Zambians

Journal Title: Journal of Medical Science and Technology - Year 2015, Vol 4, Issue 1

Abstract

 B-cell Non-Hodgkin’s lymphomas are a heterogeneous disease entity, accounting for about 21 different subtypes and 85% of all NHLs. This heterogeneity often makes clinical management of these patients difficult. Currently very little is known about the immunophenotype of the B-cell NHLs in Zambia. Immunohistochemistry plays a crucial role in the proper classification, determination of prognosis and an optimum therapeutic schedule in these lymphoid malignancies. This study was aimed at characterizing the immunohistochemical expression of 5 proteins (CD10, BCL-2, BCL-6, CD23 and Cyclin D1) in 28 cases of B-cell NHLs. This was a cross-sectional study conducted to evaluate 28 conveniently sampled B-cell NHLs formalin fixed paraffin embedded tissues from the year 2012 at the University Teaching Hospital for a six month period. The following panels of primary antibodies were used: CD10, CD23, CyclinD1, BCL-2 and BCL-6 (Dako, Glostrup, Denmark). The Labelled Streptavidin Binding (LSAB) staining was used to amplify and view the reaction. Fisher’s exact test was used to indicate statistical significance of the findings. The B-cell NHLs showed positive expression to the markers as follows; Diffuse large B cell lymphoma CD10 3/11(27.4%), BCL-2 6/11(54%) and BCL-6 1/11(9.1%). Burkitt lymphoma, CD 10 4/5(80%) and BCL-6 4/5 (80%). Small lymphocytic lymphoma, CD10 1/2(50%), BCL-2 1/2(50%) and, CD 23 2/2(100%). Mantle cell lymphoma CD10 ¼(25%), BCL-2 3/4(75%) and Cyclin D1 4/4(100%). Follicular lymphoma was CD10 1/2(50%). About 4 cases (14.3%) of the B-cell NHL were unclassified and they were positive only for CD10 3/4(75%). The B-cell NHLs has shown variable expression of the surface membrane proteins. Specifically the over expression of BCL-2 and reduced expression of CD10 and BCL-6 by DLBCLwhich accounted for the majority of the B-cell NHLs is suggestive of a very aggressive NHL prevailing among indigenous black Zambians.

Authors and Affiliations

Marah Simakando, Trevor Kaile, Lidia Korolova, Evans Malyangu, Aaron Shibemba

Keywords

Related Articles

 redisposing factors of high Lipoprotein(a) in HIV positive patients on HAART at Livingstone General Hospital, Zambia.

 Lipoprotein(a) (Lp(a)) is a highly atherogenic independent risk marker for Cardiovascular disease (CVD). Current studies show that Highly Active antiretroviral Therapy (HAART) raises Lp(a) levels in HIV patients, t...

Intra articular introperative morphine causes increased postoperative demand and after total knee replacement

Objective of the study was to assess the postoperative pain relief influence of intraoperative intra-articular morphine after total knee replacement. This prospective, double-blind and randomized study included 103 patie...

 Compare the Efficacy of Escitalopram and Amitriptyline to reduce the Suicidal Risk in Depression patients

Depression is the one of the leading cause of disability for both males and females, the burden of depression is 50% higher for females than males. To evaluate and compare the efficacy of Escitalopram (SSRI) and Amitript...

Signet ring cell adenocarcinoma of the urinary bladder: A review of the literature.

Signet-ring cell carcinoma of the urinary bladder is a rare tumour which most clinicians have not encountered in their practice. We have reviewed the literature on signet-ring cell carcinoma of the urinary bladder in ord...

Tuberculosis of the Breast: A Review of the Literature

Tuberculosis of the breast is uncommon globally and its diagnosis may not be straightforward. The disease may present as breast lump, abscess or sinus and it may sometimes mimic breast cancer. A history of previous or r...

Download PDF file
  • EP ID EP111642
  • DOI -
  • Views 204
  • Downloads 0

How To Cite

Marah Simakando, Trevor Kaile, Lidia Korolova, Evans Malyangu, Aaron Shibemba (2015).  B-Cell Non-Hodgkin’s Lymphoma characterisation by immunohistochemistry in Indigenous black Zambians. Journal of Medical Science and Technology, 4(1), 46-54. https://europub.co.uk/articles/-A-111642